Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
